Federation des caisses Desjardins du Quebec’s ImmunityBio IBRX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Buy	28,819 +26,300	+1,044%	+$199K	﹤0.01%	1549
2026 Q1	$19.3K	Sell	2,519 -4,481	-64%	-$30.7K	﹤0.01%	2107
2025 Q4	$13.9K	Buy	7,000 +6,958	+16,567%	+$15.8K	﹤0.01%	2151
2025 Q3	$103	Buy	+42	New	+$108	﹤0.01%	2806
2025 Q2	–	Sell	-11,000	Closed	-$33.1K	–	2781
2025 Q1	$33.1K	Buy	+11,000	New	+$33.3K	﹤0.01%	1571

Other funds holding IBRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's IBRX Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its ImmunityBio (IBRX) stake by 1,044% in Q2 2026, buying an estimated $199K and bringing the position to 28,819 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #1549.

Federation des caisses Desjardins du Quebec first reported a position in IBRX in Q1 2025 and has held it in 5 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

Federation des caisses Desjardins du Quebec held 28,819 shares of ImmunityBio worth $252K as of Q2 2026.
Federation des caisses Desjardins du Quebec bought 26,300 ImmunityBio shares in Q2 2026, an estimated $199K.
ImmunityBio made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1549 holding.
Federation des caisses Desjardins du Quebec first reported a position in ImmunityBio in Q1 2025 and has held it in 5 quarters since.
404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.